Abstract
Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.
Keywords: Arthritis, RA, DMARDs, Diagnosis, Pathophysiology, NSAIDs, TNF modifiers, Nutraceuticals
Mini-Reviews in Medicinal Chemistry
Title: Rheumatoid Arthritis: A New Challenge in Coming Era
Volume: 10 Issue: 2
Author(s): Prarthana V. Rewatkar, Ganesh R. Kokil, Arunima Verma and Suresh Thareja
Affiliation:
Keywords: Arthritis, RA, DMARDs, Diagnosis, Pathophysiology, NSAIDs, TNF modifiers, Nutraceuticals
Abstract: Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.
Export Options
About this article
Cite this article as:
V. Rewatkar Prarthana, R. Kokil Ganesh, Verma Arunima and Thareja Suresh, Rheumatoid Arthritis: A New Challenge in Coming Era, Mini-Reviews in Medicinal Chemistry 2010; 10 (2) . https://dx.doi.org/10.2174/138955710791185136
DOI https://dx.doi.org/10.2174/138955710791185136 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fragment Based Drug Design: From Experimental to Computational Approaches
Current Medicinal Chemistry Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
Current Pharmaceutical Design Feasibility and Prospects for Anti-Inflammatory Antibodies in the Treatment and Disease Management of Influenza
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Target Sites for the Design of Anti-trypanosomatid Drugs Based on the Structure of Dihydroorotate Dehydrogenase
Current Pharmaceutical Design Editorial (Thematic Issue: Optimizing Treatment in Rheumatoid Arthritis)
Current Pharmaceutical Design Gene Therapy for Osteoinduction
Current Gene Therapy Homochiral Drugs: A Demanding Tendency of the Pharmaceutical Industry
Current Medicinal Chemistry Mesenchymal Stem Cells: A Potent Cell Source for COVID-19
Coronaviruses Rational Design and Development of RDP58
Current Pharmaceutical Design Regenerative Potential of Stem Cells Derived from Human Exfoliated Deciduous (SHED) Teeth during Engineering of Human Body Tissues
Current Stem Cell Research & Therapy The Yin and Yang of the Ghrelin Gene Products
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Metalloproteinases: potential therapeutic targets for rheumatoid arthritis
Endocrine, Metabolic & Immune Disorders - Drug Targets Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders
Current Drug Targets Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways
Anti-Cancer Agents in Medicinal Chemistry Imino-Sugar-Based Nucleosides
Current Topics in Medicinal Chemistry Mass Spectrometry Techniques: Principles and Practices for Quantitative Proteomics
Current Protein & Peptide Science Antibody Recognition of Fluorinated Haptens and Antigens
Current Topics in Medicinal Chemistry A Descriptive Analysis of Post-Chemotherapy Development of Interstitial Lung Disease Using Spontaneous Reporting Data in Japan
Current Drug Safety Can Drug Effects Help Elucidate the Pathogenesis of SLE?
Current Rheumatology Reviews